As of January 22, 2025, Ilyda SA (ILYDA.AT) has a market cap of $24.887 million USD. According to our data, Ilyda SA is ranked No.8519 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $24.89 M |
32.00%
|
Dec 30, 2024 | $18.85 M |
50.74%
|
Dec 28, 2023 | $12.51 M |
13.08%
|
Dec 29, 2022 | $11.06 M |
-12.64%
|
Dec 30, 2021 | $12.66 M |
88.44%
|
Dec 30, 2020 | $6.72 M |
74.17%
|
Dec 30, 2019 | $3.86 M |
95.37%
|
Dec 30, 2018 | $1.97 M |
-6.90%
|
Dec 28, 2017 | $2.12 M |
-46.91%
|
Dec 29, 2016 | $3.99 M |
-25.93%
|
Dec 30, 2015 | $5.39 M |
-20.16%
|
Dec 30, 2014 | $6.76 M |
84.75%
|
Dec 30, 2013 | $3.66 M |
-38.46%
|
Dec 30, 2012 | $5.94 M |
144.36%
|
Dec 29, 2011 | $2.43 M |
-24.00%
|
Dec 30, 2010 | $3.20 M |
-74.26%
|
Dec 30, 2009 | $12.43 M |
-5.21%
|
Dec 30, 2008 | $13.12 M |
-20.78%
|
Dec 30, 2007 | $16.55 M |
-5.69%
|
Dec 28, 2006 | $17.55 M |
50.76%
|
Dec 29, 2005 | $11.64 M |
56.08%
|
Dec 30, 2004 | $7.46 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Santander
SAN
|
$74.07 B |
0.604 B
|
Spain
|
Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
First Majestic Silver
AG
|
$2.70 B |
10.900 M
|
Canada
|
Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
AbbVie
ABBV
|
$298.91 B |
0.013 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Novo Nordisk
NVO
|
$335.32 B |
64.114 B
|
Denmark
|
Market Cap | = | ILYDA.AT Stock Price | * | ILYDA.AT Shares Outstanding |
= | $1.83 | * | 13.57 M | |
= | $24.89 M |